Press release from Companies: Kommuniké Från Extra Bolagsstämman i Hamlet Pharma AB

Press release from Companies: Kommuniké Från Extra Bolagsstämman i Hamlet Pharma AB

Press release from Companies: Teckningskurs för utnyttjande av teckningsoptioner serie TO 4 B i Hamlet Pharma AB (Publ) har fastställts till 2,32 SEK per aktie

Press release from Companies: Hamlet Pharma achieves full funding from the European Commission

Press release from Companies: Hamlet Pharma achieves full funding from the European Commission

Press release from Companies: Notice of extraordinary general meeting in Hamlet Pharma AB (publ)

Press release from Companies: Notice of extraordinary general meeting in Hamlet Pharma AB (publ)

Press release from Companies: Kallelse till extra bolagsstämma i Hamlet Pharma AB (publ)

Market Notices: Market notice 83/23– Hamlet Pharma AB’s shares and subscription options HAMLET B and HAMLET TO 4 B is moved to the Observation List

Press release from Companies: Hamlet Pharma AB flyttas till observationslistan

Press release from Companies: Hamlet Pharma & SelectImmune Pharma invites to a digital investor meeting on April 3rd and April 4th at 12.00 CET

Press release from Companies: Hamlet Pharma and SelectImmune Pharma merge to create an innovative pharmaceutical company with a broad and strong portfolio of projects for the treatment of cancer and infections